EXPD
42
-3
DGX
58
8
VLO
38
5
VRTX
62
2
VIX
49
-12
ALLE
32
2
XRAY
37
2
AMT
46
4
COST
63
3
ADBE
50
3
IR
79
7
MA
60
3
CTAS
52
-3
NEE
50
3
GS
78
2
HOG
43
3
HSIC
56
3
NFLX
62
3
NWSA
73
2
MCK
55
2
EXPD
42
-3
DGX
58
8
VLO
38
5
VRTX
62
2
VIX
49
-12
ALLE
32
2
XRAY
37
2
AMT
46
4
COST
63
3
ADBE
50
3
IR
79
7
MA
60
3
CTAS
52
-3
NEE
50
3
GS
78
2
HOG
43
3
HSIC
56
3
NFLX
62
3
NWSA
73
2
MCK
55
2
Financhill
Back

Royal Caribbean Group Vs. Arcus Biosciences Industry Stock Comparison

Buy
69

RCL
Royal Caribbean Group

Last Price:
136.54
Seasonality Move:
3.33%
Sell
33

RCUS
Arcus Biosciences

Last Price:
14.82
Seasonality Move:
-13.65%
Buy
69
Royal Caribbean Group (RCL) is a Buy

Is Royal Caribbean Group a Buy, Sell or Hold?

  • The current Royal Caribbean Group [RCL] share price is $136.67. The Score for RCL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • RCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Arcus Biosciences (RCUS) is a Sell

Is Arcus Biosciences a Buy, Sell or Hold?

  • The current Arcus Biosciences [RCUS] share price is $15.50. The Score for RCUS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • RCUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCL Stock Price Chart

What is Royal Caribbean Group's stock price today?

  • The Royal Caribbean Group share price today is $136.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCUS Stock Price Chart

What is Arcus Biosciences's stock price today?

  • The Arcus Biosciences share price today is $15.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCUS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 59.32 Buy
Chaikin Money Flow: 1738038 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (129.59 - 138.19) Buy
Bollinger Bands (100): (118.3 - 132.32) Buy

RCUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 41.55 Sell
Chaikin Money Flow: 449326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.6 - 17.9) Sell
Bollinger Bands (100): (15.58 - 18.62) Sell

RCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 129.37 Buy
20-day SMA: 133.71 Buy
50-day SMA: 128.48 Buy
200-day SMA: 110.99 Buy
8-day EMA: 131.5 Buy
20-day EMA: 131.75 Buy
50-day EMA: 129.28 Buy
200-day EMA: 111.95 Buy

RCUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.4 Buy
20-day SMA: 16.69 Sell
50-day SMA: 17.47 Sell
200-day SMA: 17.63 Sell
8-day EMA: 15.46 Buy
20-day EMA: 16.3 Sell
50-day EMA: 16.91 Sell
200-day EMA: 17.79 Sell

Royal Caribbean Group Earnings Growth & RCL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.23 per share, a decrease next quarter of $2.97 per share, an increase this year of $3.43 per share, and an increase next year of $1.66 per share.

Arcus Biosciences Earnings Growth & RCUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.10 per share, and a decrease next year of $0.28 per share.

Royal Caribbean Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arcus Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):